Increasing Prevalence of IBS to Augment Growth of the Irritable Bowel Syndrome Treatment Market

Irritable Bowel Syndrome Treatment Market


 Irritable bowel syndrome (IBS) is one of the common disorders of the large intestine. Signs and symptoms include gas, bloating, abdominal pain, cramping, and constipation or diarrhea, or both. A diagnosis is often made based on symptoms. Simple changes in diet and lifestyle often provide relief from IBS. Others need medication and counselling. Medications approved for the treatment of IBS include Alosetron (Lotronex), Eluxadoline (Viberzi), Rifaximin (Xifaxan), Lubiprostone (Amitiza), and Linaclotide (Linzess).

Market Dynamics:

Increasing incidence or prevalence of irritable bowel syndrome (IBS) worldwide, especially in North America, is expected to augment the growth of the irritable bowel syndrome treatment market. For instance, according to the International Foundation for Gastrointestinal Disorders (IFFGD), around 45 million people in the United States suffer from IBS. About 2 in 3 IBS sufferers are female and about 1 in 3 are male.

Moreover, strategic initiatives undertaken by government and non-government organizations, to increase awareness among people about IBS, are expected to propel the growth of the irritable bowel syndrome treatment market. For instance, in April 2020, IFFGD will join caregivers, family members, and patients to increase public awareness about IBS.

Increasing penetration of advanced technologies, such as artificial intelligence (AI), in the healthcare industry is expected to offer lucrative growth opportunities for layers in the market. For instance, a report published in the Journal of Medical Internet Research, in March 2021, found preliminary evidence that Heali, an app that uses AI to make personalized nutrition simple, may provide therapeutic benefits to users with IBS. The app shown to improve quality of life by 2.6x in patients with IBS in randomized controlled trial

Competitive Analysis:

Major players operating in the irritable bowel syndrome treatment market are Synergy Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., GlaxoSmithKline Plc. Novartis AG, Astellas Pharma Inc., Ardelyx, Inc., Sucampo Pharmaceuticals, Inc., Abbott Laboratories, and Valeant Pharmaceuticals International, Inc.

Major market players are adopting various strategies, such as research and development, to develop safe and effective IBS treatment. For instance, in March 2021, Arena Pharmaceuticals announced topline results from Phase 2b CAPTIVATE clinical trial evaluating three doses of olorinab, a novel, oral, peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, in participants with abdominal pain due to Irritable Bowel Syndrome (IBS).

In November 2020 Urovant Sciences announced topline data from its Phase 2a study of vibegron for the treatment of irritable bowel syndrome (IBS) pain that did not meet its primary endpoint.

Comments

Post a Comment

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Image
  Whiskey or single malt whiskey is simply a form of distilled beverage made by distilling alcohol from grain mash or even by blending both. Different grains are utilized for different types, such as corn, barley, rye, and wheat. In Scotland, they call their whiskey black tea, a lighter caramel scotch, Irish cream, and liqueur. Whichever form is utilized, the result is usually a flavorful and smooth drink that has a distinct taste, and many people prefer a whiskey with a lower alcohol content. For example, single malt whiskey is the least expensive. The highest price however is the least distilled; that is Bourbon whiskey. Bourbon whiskey is the most popular whiskey in America and in many other countries around the world. Its price range is very wide, starting from as low as about US$ 12 a bottle to over a hundred dollars. So the price definitely varies. Whichever class you belong to, there is always a whiskey that will suit your preference. Single malt scotch whiskey is made ...
Read more

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Image
  Viral Vectors are proteins that have been discovered to be essential for the spread of various viruses and infectious agents. These proteins can cause serious health risks if they are improperly introduced or if a wrong agent is used to fight them off. Viral vectors have often been used in various gene therapy procedures with the ultimate objective of curing various ailments in the biological fields of neurology, gene therapy, cancer, and metabolic disorder. Clinical studies regarding viral vectors remain one of the key factors in the manufacturing of viral vectors. Plasmids are used to deliver DNA contain genes for antibiotic resistance. In fact, scientists have developed many uses of plasmids and created software to record the DNA sequences of plasmids for applications in various techniques. Thus, such continuous R&D activities can potentially stimulate growth of the viral vectors and plasmid DNA manufacturing market . Recently, in April 2021, Oxford Biomedica plc entered...
Read more

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)

Image
  There are many reasons why people choose hard surface floors over other types of flooring. Hard surfaces offer a level of durability and are very aesthetically pleasing. Unfortunately, choosing this type of flooring can be confusing and costly. There are four main hard surface varieties namely vinyl plank, laminate, solid hardwood, and engineered wood. Each has their own style strengths and provide different advantages. Increasing population coupled with rapid urbanization is expected to drive growth of the global hard surface flooring market . According to the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. According to the same source, in 2018, around 4.2 billion people were living in urban areas, increasing from 751 million in 1950. Furthermore, according to the World Bank, in 2019, the global population reached 7.674 billion, increasing from 6.84 billion in 2009. As a result of this, building...
Read more